Latest stories on ANRO
Alto Neuroscience, Inc. (ANRO) files 8-K
SEC 8-K50 · neutralgeneral
Alto Neuroscience Highlights Strong Cash, Expands ALTO-207 Trials
TipRanks63 · neutralproduct/pr
Alto Neuroscience announces pricing of $100M underwritten registered direct offering of common stock
Seeking Alpha26 · bearishgeneral
Alto Neuroscience, Inc. (ANRO) files 8-K
SEC 8-K50 · neutralgeneral
Is Alto Neuroscience, Inc. (ANRO) Stock Positioned for Growth With New Insights Into Anhedonia Treatment?
Yahoo Finance57 · neutralanalyst
Alto Neuroscience Appoints Andrew Miller to Board
TipRanks55 · neutralgeneral
Alto Neuroscience Appoints Karuna Therapeutics Founder Andrew Miller, Ph.D. to Board of Directors | ANRO Stock News
StockTitan63 · neutralgeneral